Equity Fundraising
TANFAC Raises ₹250 Crore Through Qualified Institutional Placement to Accelerate Strategic Growth
NSE
not listed
BSE
506854
TANFAC Industries Limited has successfully raised ₹250 crore through a Qualified Institutional Placement (QIP), marking its first equity capital raise in over three decades. The proceeds will be utilized to expand its fluorochemical manufacturing capabilities, strengthen backward integration, and support long-term strategic growth.
PRICE-SENSITIVE TRIGGER
Event: Successful completion of Qualified Institutional Placement (QIP).
Type: Equity Fundraising
Impact: Positive
Immediate Effect: The fund raise strengthens TANFAC’s balance sheet and provides capital to expand manufacturing capacity, execute strategic projects, and support future growth initiatives.
Key Metrics:
- Funds Raised: ₹250 crore
- Issue Type: Qualified Institutional Placement (QIP)
- Issue Launch Date: 23 June 2026
- Issue Closing Date: 25 June 2026
- Issue Price: ₹1,985.83 per equity share
- Floor Price: ₹2,090.34 per equity share
- Discount to Floor Price: 5%
- Estimated Long-term Customer Contracts: Approximately ₹3,612 crore
Highlight:
- Capital Raised: ₹250 crore
What Happened ?
TANFAC Industries Limited announced the successful completion of a ₹250 crore Qualified Institutional Placement (QIP) aimed at accelerating its long-term expansion strategy.
The issue attracted participation from several prominent domestic and global institutional investors, including Motilal Oswal Mutual Fund & AIF, Malabar Investments, 360ONE, Niveshaay Funds, and Bengal Finance & Investment (Lucky Group).
According to the company, the proceeds will primarily finance the proposed HCFC-32 refrigerant gas manufacturing plant, expansion of downstream fluorinated chemical capacities, and general corporate purposes.
Key Details
Strategic Highlights:
- Successfully completed a ₹250 crore Qualified Institutional Placement.
- First equity capital raise undertaken by the company in more than 30 years.
- Funds will support establishment of the proposed HCFC-32 refrigerant gas manufacturing facility.
- Capital will also be used for expanding downstream fluorochemical production capacities.
- Investments in hydrofluoric acid (HF) and sulphuric acid capacities will strengthen backward integration.
- Backward integration is expected to improve raw material security, enhance cost competitiveness and support operating margins.
- Institutional participation indicates strong investor confidence in TANFAC’s long-term growth strategy.
Demand Visibility:
- Secured three long-term customer arrangements supporting future capacity utilization.
- Agreement with one of India’s leading air-conditioning and commercial refrigeration companies valued at approximately ₹61 crore.
- Seven-year supply agreement with a Japanese customer valued at approximately ₹2,362 crore.
- Memorandum of Understanding to supply 5,000 MT per annum to a large multinational company for five years with an estimated value of ₹1,250 crore.
- Aggregate value of these long-term arrangements is approximately ₹3,612 crore over 5–7 years.
Note:
- The company indicated that the QIP proceeds are intended to strengthen its presence in high-value refrigerant gases and value-added fluorochemical products while supporting future capacity expansion.
Risk Analysis
Summary:
- The success of the capital raise improves financial flexibility; however, timely project execution, commissioning of new capacities, and realization of long-term demand remain important execution risks.
Key Risks:
- Delay in setting up the proposed HCFC-32 manufacturing plant.
- Project execution and commissioning risks.
- Demand or pricing changes in fluorochemical markets.
- Cost overruns during expansion projects.
- Dependence on successful execution of long-term customer contracts.
Worst Case:
- Any delay in project execution or slower-than-expected commercialization could postpone revenue generation and reduce expected returns from the newly raised capital.
Risk Level: Medium
Company Commentary
- The QIP represents an important milestone in TANFAC’s growth journey.
- Institutional participation reflects confidence in the company’s long-term business strategy.
- Funds will primarily finance the HCFC-32 refrigerant gas project, downstream fluorochemical expansion, and general corporate purposes.
- Long-term customer contracts provide strong demand visibility for upcoming capacities.
- Expanded backward integration is expected to improve raw material security, enhance cost competitiveness, and strengthen operating margins.
Official Exchange Filing: TANFAC Industries Limited
